Literature DB >> 12529295

Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML.

Shaun R McCann, Kathy Gately, Eibhlin Conneally, Mark Lawler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12529295     DOI： 10.1182/blood-2002-09-2932

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?

Authors:  Shaun R McCann
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

2.  Two different point mutations in ABL gene ATP-binding domain conferring Primary Imatinib resistance in a Chronic Myeloid Leukemia (CML) patient: A case report.

Authors:  Zafar Iqbal; Rubina T. Siddiqui; Javed A. Qureshi
Journal:  Biol Proced Online       Date:  2004-07-01       Impact factor: 3.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.